21.11.2017
- European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...
16.09.2014
- Roche's cancer drug Avastin as a cheaper treatment for wet age-related macular degeneration (wAMD), a leading cause of blindness in the elderly, does not appear to increase deaths...
07.10.2013
- German healthcare company Merck expects to get a long-term boost from study results in June that showed its main cancer drug Erbitux has an edge over rival product Avastin. Erbitux...
07.02.2013
- Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...
14.12.2012
- Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments. In the past, pharmaceutical companies could...
23.10.2012
- Europe's drugs regulator has started an infringement procedure against Swiss pharmaceutical group Roche Holding to investigate its alleged failure to report fully tens of thousands...
26.07.2012
- Swiss drugmaker Roche Holding took $1.7 billion in restructuring charges it said should lead to big savings as it confirmed its outlook on Thursday with first-half sales beating...
12.04.2012
- Swiss drugmaker Roche dangled the prospect of a higher offer before reluctant U.S. bid target Illumina on Thursday along with broadly flat first-quarter sales supported by its top...
